Autoantibody-defined risk for Type 1 diabetes mellitus in a general population of schoolchildren: results of the Karlsburg Type 1 Diabetes Risk Study after 18 years

Diabet Med. 2015 Aug;32(8):1008-16. doi: 10.1111/dme.12677. Epub 2015 Jan 23.

Abstract

Aims: To investigate the occurrence of diabetes-associated autoantibodies and cumulative Type 1 diabetes risk over 18 years in a general population of schoolchildren.

Methods: In the Karlsburg Type 1 Diabetes Risk Study, 11 986 schoolchildren from north-eastern Germany without a family history of diabetes were screened for glutamic acid decarboxylase antibodies, insulinoma-associated antigen-2 antibodies and insulin autoantibodies by radioligand binding assay. Those children found to be autoantibody-positive were invited to follow-up examinations and HLA-DQB1 genotyping, and were followed for progression to Type 1 diabetes.

Results: At first follow-up, 119 children had single and 36 children had multiple autoantibodies. Of the multiple autoantibody-positive children, 33 had at least one diabetes-associated HLA-DQB1 allele (*02 and/or *0302). A total of 26 children progressed to Type 1 diabetes, of whom 22 had multiple autoantibodies. The male-to-female ratio of those who progressed to Type 1 diabetes was 1.6. The positive predictive value of multiple autoantibodies was 61.1% compared with only 23.7% for diabetes-associated HLA-DQB1 genotypes among all those who were autoantibody-positive. The cumulative risk was 59.7% after 10 years and 75.1% after 18 years for children with multiple autoantibodies compared with 1.2 and 22.6%, respectively, for children with single autoantibodies (P<0.001). Among the three examined autoantibodies, insulinoma-associated antigen-2 antibodies conferred the highest risk.

Conclusions: The diabetes risk in schoolchildren with multiple autoantibodies was similar to the risk reported in other studies for genetically preselected probands; thus, a combined autoantibody-based screening could effectively identify at-risk individuals from the general population for future intervention trials.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Alleles
  • Autoantibodies / immunology*
  • Child
  • Diabetes Mellitus, Type 1 / epidemiology
  • Diabetes Mellitus, Type 1 / genetics
  • Diabetes Mellitus, Type 1 / immunology*
  • Female
  • Genetic Predisposition to Disease
  • Genotype
  • Germany / epidemiology
  • Glutamate Decarboxylase / immunology*
  • HLA-DQ beta-Chains / genetics
  • Humans
  • Insulin Antibodies / immunology*
  • Longitudinal Studies
  • Male
  • Predictive Value of Tests
  • Prospective Studies
  • Repressor Proteins / immunology*
  • Risk Factors
  • Seroepidemiologic Studies
  • Sex Distribution
  • Young Adult

Substances

  • Autoantibodies
  • HLA-DQ beta-Chains
  • HLA-DQB1 antigen
  • Insulin Antibodies
  • Repressor Proteins
  • INSM1 protein, human
  • Glutamate Decarboxylase